| 1 |
Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-?/CD44 cells inflammatory cascade |
|
| | Rehab M. El-Sayed,Rehab E. Abo El Gheit,Ghada A. Badawi | | | Life Sciences. 2021; 272: 119224 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review |
|
| | HayderM Al-Kuraishy,AliI Al-Gareeb,MarwaThaier Naji,Farah Al-Mamorry | | | Brain Circulation. 2020; 6(1): 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF–?B pathway and activation of Nrf2/ARE pathway in rats |
|
| | Wenjing Song,Weinan Yin,Liang Ding,Yang Gao,JingJing Xu,Yan Yang,Xin He,Pengju Gong,Lei Wei,Wenli Chen,Jingwei Zhang | | | International Urology and Nephrology. 2020; | | | [Pubmed] [Google Scholar] [DOI] | |
|
